| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |